U.S. healthcare giant Johnson & Johnson (JNJ) has accepted cash offer for its 13.5% percent stake in Belgian drugmaker Movetis NV (EBR:MOVE), $569 million takeover from Shire PLC (SHP.LN). In August, Shire offered to buy Movetis for EUR19 a share to expand its gastrointestinal medicines unit. Johnson & Johnson owns a stake of about 13.5% in [...]